Repaglinide
Showing 1 - 25 of 78
Malaria Trial in Belfast (Midazolam, Repaglinide, Dextromethorphan)
Completed
- Malaria
- Midazolam
- +7 more
-
Belfast, Northern Ireland, United KingdomNovartis Investigative Site
Nov 2, 2022
Healthy Participants Trial in Salt Lake City (DC-806, Midazolam, Repaglinide)
Not yet recruiting
- Healthy Participants
- DC-806
- +4 more
-
Salt Lake City, UtahICON Phase 1 Clinic
Oct 16, 2023
Rheumatoid Arthritis Trial in Wuhan (SHR0302 Tablets, Midazolam Maleate Tablets, Warfarin Sodium Tablets)
Completed
- Rheumatoid Arthritis
- SHR0302 Tablets
- +5 more
-
Wuhan, Hubei, ChinaZhongnan Hospital of Wuhan University
Dec 21, 2022
Sickle Cell Disease Trial in San Antonio (Voxelotor, Bupropion, Repaglinide)
Recruiting
- Sickle Cell Disease
- Voxelotor
- +8 more
-
San Antonio, TexasICON Early Phase Services, LLC
Jul 31, 2023
GIST - Gastrointestinal Stromal Tumor Trial in Jacksonville, Miami, Portland (Ripretinib, Repaglinide)
Recruiting
- GIST - Gastrointestinal Stromal Tumor
- Ripretinib
- Repaglinide
-
Jacksonville, Florida
- +2 more
Mar 7, 2022
Prostate Cancer Patients Trial in Changsha (Repaglinide, Bupropion and SHR3680)
Recruiting
- Prostate Cancer Patients
- Repaglinide, Bupropion and SHR3680
-
Changsha, Hunan, ChinaHunan Cancer Hospital
Dec 7, 2020
Type 2 Diabetes Trial in China (INSULIN GLARGINE (HOE901), Insulin Glulisine, Biphasic insulin aspart 30)
Completed
- Type 2 Diabetes Mellitus
- INSULIN GLARGINE (HOE901)
- +5 more
-
China, ChinaCHINA
Apr 21, 2022
Mitochondrial Disease Trial in Leeds (KL1333, Flurbiprofen, Dextromethorphan)
Completed
- Mitochondrial Disease
- KL1333
- +7 more
-
Leeds, United KingdomVolunteer recruitment center Covance Leeds Covance Leeds
Oct 19, 2021
Diffuse Large B Cell Lymphoma, Primary Mediastinal Lymphoma, Mantle Cell Lymphoma Trial in Tucson, Tampa, New York
Completed
- Diffuse Large B Cell Lymphoma
- +4 more
- Tazemetostat
- +3 more
-
Tucson, Arizona
- +2 more
Mar 23, 2021
Chronic Kidney Disease, Diabetes, Type 2, Hypertension Trial in Genova (Dapagliflozin 10mg Tab, Placebo)
Recruiting
- Chronic Kidney Disease
- +2 more
- Dapagliflozin 10mg Tab
- Placebo
-
Genova, GE, ItalyIRCCS Ospedale Policlinico San Martino
Aug 10, 2023
Healthy Adult Subjects Trial in Dallas (Omaveloxolone, Midazolam oral solution, Repaglinide 1 MG)
Completed
- Healthy Adult Subjects
- Omaveloxolone
- +8 more
-
Dallas, TexasCovance Clinical Research Unit (CRU) Inc.
Jan 14, 2020
Diabetes Trial in Trondheim (metformin+ NPH insulin, metformin + sitagliptin +/- repaglinide)
Completed
- Diabetes
- metformin+ NPH insulin
- metformin + sitagliptin +/- repaglinide
-
Trondheim, NorwayValdemar Grill
Jan 8, 2020
Diabetes, Type 2 Trial in Leicester, Birmingham (Canagliflozin, Repaglinide, Pioglitazone)
Completed
- Diabetes Mellitus, Type 2
- Canagliflozin
- +4 more
-
Leicester, Leicestershire, United Kingdom
- +1 more
Jan 29, 2020
Diabetes, Type 2 Trial in Palermo (Liraglutide injection, Insulin Glargine)
Completed
- Diabetes Mellitus, Type 2
- Liraglutide injection
- Insulin Glargine
-
Palermo, ItalyInternal Medicine Ward, University of Palermo
May 3, 2022
Diabetes Trial in Palermo (Dulaglutide, Aspart insulin, Glargine)
Completed
- Diabetes Mellitus
- Dulaglutide
- +4 more
-
Palermo, ItalyInternal Medicine Ward, University of Palermo
Jan 29, 2019
Covid19, Type 2 Diabetes Trial in Kuwait City, Doha (Pioglitazone 45 mg)
Unknown status
- Covid19
- Type 2 Diabetes
- Pioglitazone 45 mg
-
Kuwait City, (Pick From List), Kuwait
- +4 more
Mar 15, 2021
Type 2 Diabetes Trial in Miami, Atlanta, New York (Liraglutide + OADs, Glargine + OADs)
Completed
- Type 2 Diabetes
- Liraglutide + OADs
- Glargine + OADs
-
Miami, Florida
- +4 more
Oct 5, 2021
Diabetes, Pulmonary Tuberculosis Trial in Bandung, Lima, Bucharest (intensive monitoring)
Completed
- Diabetes Mellitus
- Pulmonary Tuberculosis
- intensive monitoring
-
Bandung, West Java, Indonesia
- +2 more
Apr 17, 2019
Diabetes, Diabetes, Type 2 Trial in Beijing, Shanghai (repaglinide, metformin)
Completed
- Diabetes
- Diabetes Mellitus, Type 2
- repaglinide
- metformin
-
Beijing, Beijing, China
- +2 more
Feb 17, 2017